-
Quote
-
0
login to like this post
Post
by BBCDoc » Sun, 26 Apr 2020 10:02 pm
Antibody testing is very dependent on good assays, because you may have to test individuals up to 3 times to understand their status, spanning several weeks. This, it is far from simple to do an antibody test on the population as you only get a cross-sectional snapshot of a dynamic situation.
HBV has the best antibody testing practice, followed by HIV and HCV. All those have had DECADES of development to get them to current standards. COVID barely has 2 months of development.
Most countries are focused on RT-PCR as the reference method for determining active infection and making real clinical decisions on patient management.
TBH, there is a lot of dogshit tests on the market now. I work in the lab testing industry, and would prefer to spend up to 18 months building a solid assay before releasing to the market - depending on a few things being available and cost not an issue.
The things I have mentioned - poor immunity and reinfection - these screw up the value of antibody testing big time.
Sent from my iPhone using Tapatalk
There's always room for one more